 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
Industry-Backed Bill Introduced in House as Frustration Grows over CMS Payment Process for MDx
October 03, 2012
Industry-Backed Bill Introduced in House as Frustration Grows over CMS Payment Process for MDx
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Lab Industry, Pathologists Still at Odds Over Fee Schedule for New Molecular Pathology CPT Codes
July 18, 2012 / Pharmacogenomics Reporter - In Information-Gathering Mode, CMS Undecided on Payment Structure for Genetic Tests
July 20, 2011 / Pharmacogenomics Reporter - CMS Asks Labs to Submit New Molecular Dx Codes Alongside Stacked CPT Codes in 2012
December 21, 2011 / Pharmacogenomics Reporter - Genomic Health Attributes Q3 Revenue Growth to Strong International Test Adoption
November 14, 2012 / Pharmacogenomics Reporter - CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns
September 19, 2012 / Pharmacogenomics Reporter